Veeva Systems (NYSE:VEEV) Upgraded to Buy at Truist Financial

Truist Financial upgraded shares of Veeva Systems (NYSE:VEEV) from a hold rating to a buy rating in a report released on Thursday, Marketbeat reports.

Other equities analysts have also recently issued reports about the company. KeyCorp restated a “sector weight” rating on shares of Veeva Systems in a report on Friday, December 12th. Jefferies Financial Group reissued a “buy” rating and set a $330.00 price target on shares of Veeva Systems in a research report on Monday, November 24th. Canaccord Genuity Group reissued a “buy” rating on shares of Veeva Systems in a research note on Tuesday, November 25th. Citigroup dropped their price objective on shares of Veeva Systems from $349.00 to $319.00 and set a “buy” rating for the company in a report on Monday, November 24th. Finally, BTIG Research reiterated a “buy” rating and set a $340.00 target price on shares of Veeva Systems in a report on Friday, November 21st. Nineteen investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $307.42.

Veeva Systems Stock Performance

Shares of Veeva Systems stock opened at $241.31 on Thursday. Veeva Systems has a one year low of $201.54 and a one year high of $310.50. The company has a market cap of $39.67 billion, a price-to-earnings ratio of 46.95, a PEG ratio of 1.77 and a beta of 1.07. The business’s 50 day moving average price is $247.98 and its 200 day moving average price is $271.38.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.95 by $0.09. The company had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The firm’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.75 EPS. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. On average, analysts predict that Veeva Systems will post 4.35 EPS for the current fiscal year.

Veeva Systems declared that its Board of Directors has initiated a stock repurchase plan on Monday, January 5th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the technology company to repurchase up to 5.5% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On Veeva Systems

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Baker Tilly Wealth Management LLC boosted its position in shares of Veeva Systems by 11.3% during the 4th quarter. Baker Tilly Wealth Management LLC now owns 1,757 shares of the technology company’s stock worth $392,000 after purchasing an additional 179 shares in the last quarter. NorthCrest Asset Manangement LLC increased its position in Veeva Systems by 0.6% during the fourth quarter. NorthCrest Asset Manangement LLC now owns 54,560 shares of the technology company’s stock worth $12,075,000 after buying an additional 315 shares in the last quarter. Gryphon Financial Partners LLC raised its holdings in shares of Veeva Systems by 7.8% in the fourth quarter. Gryphon Financial Partners LLC now owns 1,212 shares of the technology company’s stock worth $271,000 after acquiring an additional 88 shares during the last quarter. Nordea Investment Management AB boosted its stake in shares of Veeva Systems by 8.3% during the 4th quarter. Nordea Investment Management AB now owns 566,533 shares of the technology company’s stock worth $126,654,000 after purchasing an additional 43,286 shares during the last quarter. Finally, New England Research & Management Inc. raised its holdings in Veeva Systems by 274.0% in the 4th quarter. New England Research & Management Inc. now owns 8,415 shares of the technology company’s stock valued at $1,878,000 after acquiring an additional 6,165 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Key Headlines Impacting Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva and BioMarin announced a long‑term strategic partnership to accelerate development and commercialization workflows — strengthens a customer relationship with recurring revenue and cross‑sell potential. Veeva and BioMarin Form Long-Term Strategic Partnership
• Positive Sentiment: Veeva launched an Environmental Monitoring solution to modernize quality‑control in manufacturing — expands Veeva’s manufacturing QC portfolio and creates new upsell opportunities to regulated customers. Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
• Positive Sentiment: Novo Nordisk’s International Operations committed to Veeva Vault CRM — a significant commercial win that validates Veeva’s CRM and agentic AI positioning and can drive multi‑year recurring revenue. Novo Nordisk International Operations Commits to Veeva Vault CRM
• Positive Sentiment: The board authorized up to $2 billion to repurchase Class A shares — a sizable buyback that should support EPS and reduce float, typically viewed positively by investors. Veeva authorized to purchase up to $2B of shares of Class A stock
• Positive Sentiment: Analyst sentiment improved — Truist upgraded VEEV from hold to buy, and Stifel Nicolaus also published a buy — upgrades can lift demand and broker coverage. Veeva Systems (VEEV) Gets a Buy from Stifel Nicolaus
• Neutral Sentiment: Veeva will present at the J.P. Morgan 2026 Healthcare Conference — useful for investor visibility but not an immediate fundamental change. Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
• Neutral Sentiment: Multiple press stories noted the stock is trading up — reflects market reaction to the combination of the above items rather than new company fundamentals. Veeva Systems (VEEV) stock trades up, here is why

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.